Powered by
Estar Technologies Ltd. Files an Opposition to Regen Lab Patent in the European Patent Office (EPO)
Mar 2, 2017 - ICT Monitor Worldwide

(PRWeb) - Estar Technologies Ltd. ("Estar"), a world recognized developer and manufacturer of innovative medical technologies in the biologics and platelet rich plasma (PRP) fields for the treatment of damaged soft and hard tissue, filed a notice of opposition requesting the European Patent Office (EPO) to completely revoke European Patent No. 2,073,862 B1 in the name of Antoine Turzi, exclusively licensed to Regen Lab SA. If successful, the opposition will lead to the complete invalidation and

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox